Welcome to our dedicated page for Marchex SEC filings (Ticker: MCHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marchex, Inc. filings document the regulatory record for a Delaware operating company that provides AI-based conversational intelligence and analytics solutions. Its disclosures cover operating and financial results, material agreements, capital-structure matters, governance actions, legal proceedings, and risk factors tied to its conversational analytics business.
Recent filings include Form 8-K material-event reports, proxy materials for annual meeting matters, and compensation disclosures involving cash awards, restricted stock units, stock options, and the 2021 Stock Incentive Plan. The filings also describe the company's Class A and Class B common stock voting structure, board and stockholder voting matters, lease-related agreements and impairments, and settlement documentation for civil litigation.
Marchex, Inc. is asking holders to approve a proposed acquisition of Archenia, Inc. at a Special Meeting on July 1, 2026.
The Purchase Price consists of an aggregate $10,000,000 in convertible promissory notes bearing 6% interest (convertible into Class B shares at $1.80 per share) and potential Earn-out Consideration of 2,000,000 shares of Class B common stock for each of the first and second 12-month performance periods following closing. The Sellers include Chairman Russell C. Horowitz and Vice Chairman Michael Arends; a Special Committee of independent directors negotiated the Transaction and the Board unanimously recommends approval.
Stockholder approval requires (a) a majority of voting power of all issued and outstanding Class A and Class B shares and (b) a Majority of the Minority Vote disregarding shares owned by Horowitz and Arends; on the record date there were 4,660,927 Class A shares and 39,660,339 Class B shares outstanding.
Marchex, Inc. is asking stockholders to approve its acquisition of Archenia, Inc., with consideration including $10.0 million in convertible promissory notes and potential 2,000,000 Class B shares per 12‑month performance period as earn‑outs.
The notes bear 6% interest, pay in three tranches at 12/18/24 months and are convertible at $1.80 per Class B share; earn‑out issuances depend on revenue or Adjusted EBITDA and specified integration or customer retention targets. Closing is conditioned on stockholder approval (including a Majority of the Minority Vote) and other closing conditions.
Marchex, Inc. reported a smaller loss while revenue declined for the quarter ended March 31, 2026. Revenue was $10.6 million, down from $11.4 million a year earlier, and net loss narrowed to $1.7 million, or $0.04 per share for both Class A and B.
Cash and cash equivalents were $9.0 million, with total assets of $38.5 million and stockholders’ equity of $28.9 million. Operating cash outflow improved to $0.5 million from $2.6 million as working-capital swings moderated.
The company recorded a $0.2 million impairment tied to subleasing its Seattle headquarters and finalized a $2.1 million settlement related to the Telmetrics acquisition, payable through 2027. Marchex also signed a stock purchase agreement to acquire Archenia, Inc. for $10.0 million in 6% convertible notes plus up to 4.0 million Class B earnout shares, subject to approval by disinterested stockholders.
Marchex, Inc. reported first quarter 2026 results and outlined plans to acquire Archenia, Inc. Revenue was $10.6 million, down from $11.4 million a year earlier. Net loss narrowed to $1.7 million or $(0.04) per diluted share, versus a $2.0 million loss or $(0.05) per share in 2025.
Adjusted EBITDA was a loss of $0.1 million, improving from a $0.8 million loss; excluding $0.7 million of reorganization and acquisition costs, Adjusted EBITDA would have been a $0.6 million gain. For Q2 2026, Marchex anticipates sequential revenue growth and projects Adjusted EBITDA of $1.6–$1.8 million, with potential to reach about $2 million in Q3 on a stand-alone basis and $2.5 million with Archenia.
Marchex entered a Stock Purchase Agreement to acquire 100% of Archenia, a performance-based, AI-driven customer acquisition company, subject to approval by a majority of disinterested stockholders and other closing conditions. Marchex estimates the combined business could reach an annualized revenue run rate of about $60 million with Adjusted EBITDA margins of 10% or more in 2026.
Marchex, Inc. has signed a Stock Purchase Agreement to acquire 100% of Archenia, Inc. for a base consideration of $10 million in convertible promissory notes. The notes carry 6% interest, are payable in three equal tranches over 12, 18 and 24 months after closing, and are convertible into Class B common stock at $1.80 per share.
Marchex may also issue up to 4 million additional Class B shares as earn-out consideration, with 2 million shares potentially issuable for each of the first two 12‑month periods after closing if Archenia exceeds prior‑period revenue or Adjusted EBITDA and meets integration and customer retention targets. The transaction requires approval by a majority of disinterested stockholders and other closing conditions, and was approved by a special committee of independent directors, which obtained a fairness opinion on the purchase price.
Marchex, Inc. entered into a Sublease Agreement with RentSpree, Inc. for its 12,300 square foot office space at 1200 5th Avenue, Suite 1300, Seattle, Washington. The term runs from May 1, 2026 through September 28, 2027.
RentSpree will pay fixed monthly rent over the term totaling approximately $337,000, with an initial rate of $19.25 per square foot, increasing after 12 months to $19.50 per square foot. In connection with this sublease, Marchex determined that the carrying value of its right‑of‑use asset for the space exceeds its estimated fair value and will record a noncash impairment charge of approximately $203,000 in its consolidated statement of operations for the quarter ending March 31, 2026.
Marchex, Inc. filed Amendment No. 1 to its annual report to add Part III disclosures on directors, executive officers, compensation, ownership and auditor fees instead of incorporating a future proxy statement by reference. The filing details a five-member board, committee structures, and independence determinations.
Marchex highlights a strong 2023 say-on-pay result, with about 95% of votes supporting named executive officer pay, and continues its mix of salary, bonus and equity awards under the 2021 Stock Incentive Plan. In 2025, President & CRO Troy Hartless received total compensation of $1,230,833, while former CEO Edwin Miller received $857,340.
The company reports dual-class equity with 4,660,927 Class A and 39,636,247 Class B shares outstanding as of April 10, 2026, and notes that directors and executives as a group control 78.5% of total voting power. For 2025, Marchex recorded a net loss of $5,235K and paid $606,890 in audit fees to RSM US LLP.
Marchex, Inc. entered into a Settlement Agreement to resolve the civil action Chris Barnard and Sinc McEvenue v. Marchex, Inc. previously disclosed in its 2025 Form 10-K. The agreement covers the expected settlement amount already accrued in the 2025 consolidated financial statements.
Under the agreement, Marchex will pay $750,000 and allow the release of $250,000 held in escrow on or before May 14, 2026, followed by payments of $500,000 on November 16, 2026 and May 17, 2027, resolving all claims related to this matter.
Marchex, Inc. files its annual report describing a business built around AI-powered conversation intelligence for enterprises that depend on phone calls, texts and other channels to acquire and serve customers, especially in B2B2C verticals like automotive and home services.
The company offers products such as Marketing Edge, Sonar Business Text Messaging, Marchex Platform Services, Spotlight, Engage, and AI-driven Call Summary and Sentiment Suite, all aimed at turning conversations into measurable sales and customer-experience improvements. It highlights growing use of generative AI, large language models and industry-specific analytics as key differentiators.
Marchex also discloses significant risk factors: an accumulated deficit of $331.4 million as of December 31, 2025, revenue concentration with the five largest customers representing about 36% of 2025 revenue, intense competition from larger technology and communications players, and evolving AI, privacy, telecommunications and TCPA regulations. As of March 19, 2026, the company had 4,660,927 Class A and 39,249,271 Class B shares outstanding and employed 139 full-time staff as of December 31, 2025.
Marchex, Inc. reported lower 2025 results but highlighted improving underlying profitability and a planned AI-focused acquisition. GAAP revenue was $10.8 million in Q4 2025 versus $11.9 million a year earlier, with full-year 2025 revenue of $45.4 million versus $48.1 million. Net loss was $2.3 million in Q4 2025 and $5.2 million for 2025, slightly wider than 2024. However, adjusted EBITDA was a loss of $0.7 million for 2025, and excluding $2.6 million of reorganization and acquisition-related costs, management indicates adjusted EBITDA would have been a $1.9 million gain.
For 2026, Marchex anticipates Q1 revenue roughly in line with Q4 2025 and adjusted EBITDA of at least $500,000, rising to more than $1 million in Q2 as revenue grows sequentially. Management targets 2026 revenue run-rate growth of about 10% from 2025 year-end levels and adjusted EBITDA margins of 10% or more. Marchex also updated progress on its proposed acquisition of Archenia, Inc., which estimates more than $17 million of 2025 revenue with positive adjusted EBITDA, and projects the potential combined company could reach approximately $60 million in annualized revenue in 2026 with 15–20% growth.